Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ADMA – Adma Biologics Inc

ADMA Biologics Inc
ADMA
$15.69
Name : ADMA Biologics Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,744,115,968.00
EPSttm : 0.86
finviz dynamic chart for ADMA
ADMA Biologics Inc
$15.69
3.62%
$0.59

Float Short %

8.45

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

0.04

EPS Last/This Y

-0.25

EPS This/Next Y

0.34

Price

16.28

Target Price

30

Analyst Recom

1

Performance Q

10.67

Relative Volume

0.77

Beta

0.49

Ticker: ADMA




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-13ADMA17.70.500.8579196
2026-01-14ADMA18.280.480.8478192
2026-01-15ADMA17.490.480.4478033
2026-01-16ADMA17.310.470.1977925
2026-01-20ADMA17.60.352.1127986
2026-01-21ADMA17.350.450.7031240
2026-01-22ADMA17.420.465.2232853
2026-01-23ADMA16.720.533.1434661
2026-01-26ADMA16.970.551.7235190
2026-01-27ADMA16.580.590.8036435
2026-01-28ADMA16.340.601.9336645
2026-01-29ADMA17.010.600.8036610
2026-01-30ADMA17.30.605.7136866
2026-02-02ADMA17.490.622.4237519
2026-02-03ADMA17.530.625.0537682
2026-02-04ADMA16.50.630.7837938
2026-02-05ADMA15.940.645.8538012
2026-02-06ADMA16.430.696.3139432
2026-02-09ADMA16.380.760.3941005
2026-02-10ADMA16.280.750.4841135
2026-02-11ADMA16.260.760.3141153
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-13ADMA17.7147.1- 0.60
2026-01-14ADMA18.2747.1- 0.60
2026-01-15ADMA17.5047.1- 0.60
2026-01-16ADMA17.3147.1- 0.60
2026-01-20ADMA17.6147.1- 0.60
2026-01-21ADMA17.3647.1- 0.60
2026-01-22ADMA17.4047.1- 0.60
2026-01-23ADMA16.7247.1- 0.60
2026-01-26ADMA16.9847.1- 0.60
2026-01-27ADMA16.5947.1- 0.60
2026-01-28ADMA16.3447.1- 0.60
2026-01-29ADMA17.0047.1- 0.60
2026-01-30ADMA17.3047.1- 0.60
2026-02-02ADMA17.5047.1- 0.60
2026-02-03ADMA17.5147.1- 0.60
2026-02-04ADMA16.5047.1- 0.60
2026-02-05ADMA15.9347.1- 0.60
2026-02-06ADMA16.4347.1- 0.60
2026-02-09ADMA16.3747.1- 0.60
2026-02-10ADMA16.2747.1- 0.60
2026-02-11ADMA16.2847.1- 0.60
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-13ADMA-1.533.158.25
2026-01-14ADMA-1.533.158.25
2026-01-15ADMA-1.533.158.25
2026-01-16ADMA-1.533.158.25
2026-01-20ADMA-1.282.788.25
2026-01-21ADMA-1.282.788.25
2026-01-22ADMA-1.282.788.25
2026-01-23ADMA-1.282.788.25
2026-01-26ADMA-1.282.118.25
2026-01-27ADMA-1.282.118.25
2026-01-28ADMA-1.282.118.08
2026-01-29ADMA-1.282.118.08
2026-01-30ADMA-1.282.118.08
2026-02-02ADMA-1.282.518.08
2026-02-03ADMA-1.282.518.08
2026-02-04ADMA-1.282.518.08
2026-02-05ADMA-1.282.518.08
2026-02-06ADMA-1.282.518.08
2026-02-10ADMA-1.282.928.08
2026-02-11ADMA-1.282.928.45
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.16

Avg. EPS Est. Current Quarter

0.2

Avg. EPS Est. Next Quarter

0.2

Insider Transactions

-1.28

Institutional Transactions

2.92

Beta

0.49

Average Sales Estimate Current Quarter

139

Average Sales Estimate Next Quarter

142

Fair Value

16.25

Quality Score

99

Growth Score

76

Sentiment Score

2

Actual DrawDown %

36.6

Max Drawdown 5-Year %

-62.3

Target Price

30

P/E

19.12

Forward P/E

18.19

PEG

0.52

P/S

7.93

P/B

9

P/Free Cash Flow

95.13

EPS

0.85

Average EPS Est. Cur. Y​

0.6

EPS Next Y. (Est.)

0.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

42.87

Relative Volume

0.77

Return on Equity vs Sector %

20.7

Return on Equity vs Industry %

37.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

ADMA Biologics Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 677
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading